Polar Capital Healthcare Blue Chip Fund

Select share classes

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income

Category Sector Equity Healthcare
This fund can be held in an Investment ISA, SIPP and Investment Account
Last buy/sell price

£16.24/£16.24

arrow-up£0.11 (+0.68%)

Fund Code

POHBI

BPRBXT0

IE00BPRBXT06

Prices updated as at 11 Dec 2025
|
Prices in GBP
Investment objective
The Fund’s investment objective is to achieve long term capital appreciation.
Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Please refer to the FCA website which details further information in relation to sustainability disclosure requirements for retail clients.
Important documents: Please ensure that you have read the Key Information Document/Technical Guide
, Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and the fund information documents. These can be found within the Charges & documents section.

Portfolio as of 31/10/2025

Asset allocation

Show long & short position

Geographical breakdown

Continent or country allocation (%)

Market classification (%)

Stock style

Large growth

26.04%

% Weight
Value
Core
Growth
Large

13

15

26

Medium

6

3

11

Small

0

5

21

  • Interest rate risk

    Bond %
    Avg credit quality-
    Avg wtd coupon4.52
    Modified duration-

  • Credit quality breakdown

    Rating% of Bond
    No Data

Valuation

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income
Sector Equity Healthcare

19.25

19.25
18.97

1.23

1.23
1.92

3.42

3.42
4.17

15.36

15.36
13.61

Growth rate

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income
Sector Equity Healthcare

11.68%

11.68%
9.32%

0.76%

0.76%
1.51%

14.31%

14.31%
4.08%

Top 10 holdings

1
Eli Lilly and Co
Sector
-
Country
United States
% of assets
9.80387
2
AstraZeneca PLC
Sector
-
Country
United Kingdom
% of assets
5.28941
3
Thermo Fisher Scientific Inc
Sector
-
Country
United States
% of assets
4.81584
4
Boston Scientific Corp
Sector
-
Country
United States
% of assets
4.01405
5
CVS Health Corp
Sector
-
Country
United States
% of assets
3.9685
6
Teva Pharmaceutical Industries Ltd ADR
Sector
-
Country
Israel
% of assets
3.69851
7
Insulet Corp
Sector
-
Country
United States
% of assets
3.65519
8
UCB SA
Sector
-
Country
Belgium
% of assets
3.46451
9
Fresenius SE & Co KGaA
Sector
-
Country
Germany
% of assets
3.37104
10
West Pharmaceutical Services Inc
Sector
-
Country
United States
% of assets
3.2421
Assets in top 10 holdings %

45.32%

Total no. of equity holdings

32.00

Total no. of bond holdings

-

Stock sectors

Polar Capital Funds PLC - Polar Capital Healthcare Blue Chip Fund I Income
Sector Equity Healthcare

0.00%

Basic materials

-
-

Con cyclical

-
-

Financial svs

-
-

Real estate

-
-

0.00%

Comm services

-
-

Energy

-
-

Industrials

-
-

Technology

-
-

100.00%

Con defensive

-
-

Healthcare

100.00%
-

Utilities

-
-


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.


Any ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
© Copyright 2025 Morningstar. All rights reserved.